Cargando…
Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
Autores principales: | Bowyer, Georgina, Afolabi, Muhammed O, Bliss, Carly M, Tiono, Alfred B, Drammeh, Abdoulie, Nébié, Issa, Jagne, Ya Jankey, Yaro, Jean Baptiste, Imoukhuede, Egeruan B, Flanagan, Katie L, Kampman, Beate, Viebig, Nicola, Sirima, Sodiomon B, Bojang, Kalifa, Hill, Adrian VS, Ewer, Katie J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179299/ http://dx.doi.org/10.1186/1475-2875-13-S1-P16 |
Ejemplares similares
-
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
por: Afolabi, Muhammed O, et al.
Publicado: (2016) -
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
por: Tiono, Alfred B., et al.
Publicado: (2018) -
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
por: Morter, Richard, et al.
Publicado: (2022) -
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
por: Bliss, Carly M., et al.
Publicado: (2017) -
Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
por: Ogwang, Caroline, et al.
Publicado: (2013)